All News #Library
Biotech
ABIONYX Achieves Major Milestone in apoA-I Biomanufacturing
27 Mar 2026 //
PHARMIWEB
ABIONYX Pharma Validates Apoa-I Genetic Role In Sepsis: NATURE
21 Oct 2025 //
BUSINESSWIRE
ABIONYX Wins €8.7M France 2030 Grant To Fight Sepsis
20 Feb 2025 //
BUSINESSWIRE
ABIONYX Pharma has completed a successful pre-IND the FDA for CER-001
13 Jun 2024 //
BUSINESSWIRE
Abionyx Pharma’s Phase IIa trial of CER-001 for AKI meets primary objective
17 Jan 2023 //
CLINICAL TRIALS ARENA
ABIONYX Reports Positive Results from Phase 2a Pilot Trial Evaluating CER-001
16 Jan 2023 //
BUSINESSWIRE

Market Place
Sourcing Support